We are live on ! Find out more
GSK icon

GSK
GSK

639 hedge funds and large institutions have $13.8B invested in GSK in 2013 Q2 according to their latest regulatory filings, with 639 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

43% more call options, than puts

Call options by funds: $124M | Put options by funds: $87.1M

4.49% more ownership

Funds ownership: 0% → 4.49% (+4.5%)

Holders
639
Holders Change
+639
Holders Change %
–
% of All Funds
20.85%
Holding in Top 10
14
Holding in Top 10 Change
+14
Holding in Top 10 Change %
% of All Funds
0.46%
New
639
Increased
–
Reduced
–
Closed
–
Calls
$124M
Puts
$87.1M
Net Calls
+$37.2M
Net Calls Change
+$37.2M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Brown Advisory
201
Brown Advisory
Maryland
$3.34M +$3.4M +53,505 New
KIA
202
KCM Investment Advisors
California
$3.31M +$3.36M +52,965 New
RJT
203
Raymond James Trust
Florida
$3.3M +$3.36M +52,870 New
EIP
204
Epoch Investment Partners
New York
$3.29M +$3.34M +52,605 New
FNBOMD
205
First National Bank of Mount Dora
Florida
$3.28M +$3.33M +52,435 New
MAM
206
Martingale Asset Management
Massachusetts
$3.26M +$3.31M +52,206 New
JHIU
207
Janus Henderson Investors US
Colorado
$3.23M +$3.28M +51,720 New
Fiera Capital (Canada)
208
Fiera Capital (Canada)
Quebec, Canada
$3.18M +$3.23M +50,880 New
CTC
209
Central Trust Company
Missouri
$3.16M +$3.21M +50,630 New
GHA
210
GW Henssler & Associates
Georgia
$3.14M +$3.19M +50,274 New
KJHP
211
K.J. Harrison & Partners
Ontario, Canada
$3M +$3.05M +48,000 New
LCS
212
Levin Capital Strategies
New York
$2.95M +$3M +47,243 New
FB
213
Fulton Bank
Pennsylvania
$2.9M +$2.94M +46,394 New
TD Asset Management
214
TD Asset Management
Ontario, Canada
$2.87M +$2.92M +45,958 New
HAI
215
Hennessy Advisors Inc
California
$2.8M +$2.85M +44,880 New
BF
216
BOK Financial
Oklahoma
$2.79M +$2.83M +44,649 New
Canada Pension Plan Investment Board
217
Canada Pension Plan Investment Board
Ontario, Canada
$2.76M +$2.81M +44,238 New
JAM
218
Jolley Asset Management
North Carolina
$2.76M +$2.81M +44,222 New
OPCM
219
Osborne Partners Capital Management
California
$2.74M +$2.79M +43,904 New
Susquehanna International Group
220
Susquehanna International Group
Pennsylvania
$2.66M +$2.7M +42,568 New
DCMM
221
DG Capital Management (Massachusetts)
Massachusetts
$2.64M +$2.68M +42,276 New
CRC
222
Curi RMB Capital
Illinois
$2.63M +$2.67M +42,075 New
PAWC
223
P.A.W. Capital
Connecticut
$2.6M +$2.64M +41,600 New
MHC
224
Meyer Handelman Company
New York
$2.57M +$2.61M +41,175 New
Creative Planning
225
Creative Planning
Kansas
$2.56M +$2.61M +41,070 New
7 8
9
10 11

GSK Hedge Fund Activity: Q2 2013 in Review

639 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in GSK (GSK) for Q2 2013, worth a combined $13.8B.

Buyers outnumbered sellers: 639 funds opened new GSK positions and 0 closed out — a net gain of 639 holders — while 0 added to existing stakes and 0 trimmed.

  • 639 institutional investors held GSK (GSK) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $13.8B of GSK stock for Q2 2013.
  • 639 funds opened new GSK positions in Q2 2013 and 0 closed out, a net change of +639 holders.

Based on aggregated 13F filings for Q2 2013.